These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
55 related items for PubMed ID: 24241172
1. Characterization of anti-Tn-antigen MLS128 binding proteins involved in inhibiting the growth of human colorectal cancer cells. Zamri N, Masuda N, Oura F, Kabayama K, Yajima Y, Nakada H, Yamamoto K, Fujita-Yamaguchi Y. Biosci Trends; 2013 Oct; 7(5):221-9. PubMed ID: 24241172 [Abstract] [Full Text] [Related]
2. Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells. Zamri N, Masuda N, Oura F, Yajima Y, Nakada H, Fujita-Yamaguchi Y. Biosci Trends; 2012 Dec; 6(6):303-12. PubMed ID: 23337790 [Abstract] [Full Text] [Related]
7. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism. Garrouste F, Remacle-Bonnet M, Fauriat C, Marvaldi J, Luis J, Pommier G. Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282 [Abstract] [Full Text] [Related]
15. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line. Pommier GJ, Garrouste FL, el Atiq F, Roccabianca M, Marvaldi JL, Remacle-Bonnet MM. Cancer Res; 1992 Jun 01; 52(11):3182-8. PubMed ID: 1375536 [Abstract] [Full Text] [Related]
16. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein. Culouscou JM, Shoyab M. Cancer Res; 1991 Jun 01; 51(11):2813-9. PubMed ID: 1709585 [Abstract] [Full Text] [Related]
17. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor. Perrault R, Wright B, Storie B, Hatherell A, Zahradka P. Cell Signal; 2011 Apr 01; 23(4):739-46. PubMed ID: 21215800 [Abstract] [Full Text] [Related]
18. Neurotensin-induced Erk1/2 phosphorylation and growth of human colonic cancer cells are independent from growth factors receptors activation. Massa F, Tormo A, Béraud-Dufour S, Coppola T, Mazella J. Biochem Biophys Res Commun; 2011 Oct 14; 414(1):118-22. PubMed ID: 21945442 [Abstract] [Full Text] [Related]
19. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. J Endocrinol; 2005 Jun 14; 185(3):577-92. PubMed ID: 15930183 [Abstract] [Full Text] [Related]
20. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Bauer TW, Fan F, Liu W, Camp ER, Yang A, Somcio RJ, Bucana CD, Singh R, Ellis LM. Ann Surg Oncol; 2007 Oct 14; 14(10):2838-46. PubMed ID: 17653802 [Abstract] [Full Text] [Related] Page: [Next] [New Search]